Clinical Trial Update: Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating sacubitril/valsartan (Entresto) for Peripheral Arterial Disease; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: University of Minnesota | Conditions: Peripheral Arterial Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-12-17